In vivo TSPO imaging in patients with multiple sclerosis: A brain PET study with [18F]FEDAA1106

EJNMMI Research

Volumn 3, Issue 1, 2013, Pages 1-9

  Takano, Akihiro ^a   Piehl, Fredrik ^a   Hillert, Jan ^a   Varrone, Andrea ^a   Nag, Sangram ^a   Gulyás, Balázs ^a   Stenkrona, Per ^a   Villemagne, Victor L ^b   Rowe, Christopher C ^b   Macdonell, Richard ^b   Tawil, Nabil Al ^c   Kucinski, Thomas ^a   Zimmermann, Torsten ^d   Schultze Mosgau, Marcus ^d   Thiele, Andrea ^d   Hoffmann, Anja ^d   Halldin, Christer ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b AUSTIN HEALTH   (Australia)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d BAYER PHARMA AG   (Germany)

Author keywords

Multiple sclerosis; Positron emission tomography; TSPO imaging

Indexed keywords

FEDAA 1106; FEDAA 1106 F 18; GADOLINIUM; MEMBRANE PROTEIN; RADIOLIGAND; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTERIAL BLOOD; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; IN VIVO STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBCORTEX;

EID: 84878784892     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-3-30     Document Type: Article

References (18)

1. Cosenza-Nashat M, Zhao ML, Suh HS, Morgan J, Natividad R, Morgello S, Lee SC: Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol 2009, 35:306-328.
2. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R: The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000, 123(Pt 11):2321-2337.
3. Oh U, Fujita M, Ikonomidou VN, Evangelou IE, Matsuura E, Harberts E, Fujimura Y, Richert ND, Ohayon J, Pike VW, Zhang Y, Zoghbi SS, Innis RB, Jacobson S: Translocator protein PET imaging for glial activation in multiple sclerosis. J Neuroimmune Pharmacol 2011, 6:354-61.
4. 11C]PK11195 in patients. J Neurol Sci 2008, 264:9-17.
5. Zhang MR, Maeda J, Ogawa M, Noguchi J, Ito T, Yoshida Y, Okauchi T, Obayashi S, Suhara T, Suzuki K: Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl) acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain. J Med Chem 2004, 47:2228-2235.
6. 18F]FEDAA1106: a human whole-body PET study. Eur J Nucl Med Mol Imaging 2011, 38:2058-2065.
7. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, Heiss WD: The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 1994, 18:110-118.
8. 11C]PK11195. Eur J Neurol 2003, 10:257-264.
9. Fujimura Y, Ikoma Y, Yasuno F, Suhara T, Ota M, Matsumoto R, Nozaki S, Takano A, Kosaka J, Zhang MR, Nakao R, Suzuki K, Kato N, Ito H: Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. J Nucl Med 2006, 47:43-50.
10. Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor RR, Hitzemann R, Bendriem B, Gatley SJ, Christman DR: Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990, 10:740-747.
11. Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, Antel JP: PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 1997, 50:345-353.
12. 11C-PBR28: a PET radioligand to image inflammation. J Nucl Med 2007, 48:2072-2079.
13. Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, Rhodes C, Pulford DJ, Bennacef I, Parker CA, Stjean PL, Cardon LR, Mooser VE, Matthews PM, Rabiner EA, Rubio JP: An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab 2012, 32:1-5.
14. Guo Q, Owen DR, Rabiner EA, Turkheimer FE, Gunn RN: Identifying improved TSPO PET imaging probes through biomathematics: the impact of multiple TSPO binding sites in vivo. Neuroimage 2012, 60:902-910.
15. 18F]-FEPPA. J Cereb Blood Flow Metab 2012, 32:968-972.
16. Kreisl WC, Jenko KJ, Hines CS, Hyoung Lyoo C, Corona W, Morse CL, Zoghbi SS, Hyde T, Kleinman JE, Pike VW, McMahon FJ, Innis RB: A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cereb Blood Flow Metab 2013, 33:53-58.
17. Owen DR, Gunn RN, Rabiner EA, Bennacef I, Fujita M, Kreisl WC, Innis RB, Pike VW, Reynolds R, Matthews PM, Parker CA: Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med 2011, 52:24-32.
18. Shidahara M, Ikoma Y, Seki C, Fujimura Y, Naganawa M, Ito H, Suhara T, Kanno I, Kimura Y: Wavelet denoising for voxel-based compartmental analysis of peripheral benzodiazepine receptors with [18]F-FEDAA1106. Eur J Nucl Med Mol Imaging 2008, 35:416-423.